Acerus Pharmaceuticals (ASP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Acerus UpdateMay 25, 2023 | benzinga.comClosing Bell: Acerus Pharmaceuticals Corp flat on Thursday (ASP)April 8, 2023 | theglobeandmail.comIIROC Trading Halt - ASPJanuary 26, 2023 | finance.yahoo.comAcerus Files For CCAA ProtectionJanuary 26, 2023 | finance.yahoo.comAcerus Announces New Loan Agreement With First Generation CapitalDecember 22, 2022 | finance.yahoo.comAcerus Pharmaceuticals Third Quarter 2022 Earnings: US$0.54 loss per share (vs US$0.64 loss in 3Q 2021)November 18, 2022 | finance.yahoo.comAcerus: Q3 Earnings SnapshotNovember 14, 2022 | sfgate.comAcerus to Report Q2-2022 Financial Results and Host Investor CallAugust 3, 2022 | finance.yahoo.comAcerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity SecurityholdersJune 7, 2022 | finance.yahoo.comAcerus Reports First Quarter 2022 Financial ResultsMay 10, 2022 | finance.yahoo.comAcerus Pharmaceuticals Corporation: Acerus Announces Completion of Share ConsolidationApril 27, 2022 | finanznachrichten.deStocks in play: Acerus Pharmaceuticals Corporation.March 10, 2022 | ca.finance.yahoo.comAcerus To Report Q4 And Full Year 2021 Financial Results And Host Investor CallMarch 10, 2022 | finance.yahoo.comAcerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva(TM)March 7, 2022 | stockhouse.comAcerus Announces Amendment to Loan FacilitiesFebruary 18, 2022 | finance.yahoo.comAcerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto RicoJanuary 10, 2022 | finance.yahoo.comAcerus Announces Amendments to Loan FacilitiesDecember 13, 2021 | finance.yahoo.comAcerus to Report Q3-2021 Financial Results and Host Investor CallNovember 2, 2021 | finance.yahoo.comResearch Reports Initiated on Healthcare Stocks Nuvo Pharmaceuticals, Acerus Pharmaceuticals, and AvivagenOctober 26, 2021 | finance.yahoo.comEven with Acerus Pharmaceuticals Corporation (TSE:ASP) stock down 11% this week, insiders who bought recently netted around US$102kSeptember 9, 2021 | finance.yahoo.comAcerus Pharmaceuticals Corp.August 21, 2021 | barrons.comAcerus Reports Acceptance of Part 36 Settlement Offer in Recipharm LitigationAugust 12, 2021 | finance.yahoo.comAcerus to Report Q2-2021 Financial Results and Host Investor CallAugust 3, 2021 | finance.yahoo.com Get Acerus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASP and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. ASP Media Mentions By Week ASP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASP News Sentiment▼0.000.61▲Average Medical News Sentiment ASP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASP Articles This Week▼00▲ASP Articles Average Week Get Acerus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies WLLW News Today CTX News Today MPH News Today NDVA News Today VPH News Today ENTG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:ASP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acerus Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acerus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.